Cargando…
Reversal of cognitive decline in Alzheimer's disease
Alzheimer's disease is one of the most significant healthcare problems nationally and globally. Recently, the first description of the reversal of cognitive decline in patients with early Alzheimer's disease or its precursors, MCI (mild cognitive impairment) and SCI (subjective cognitive i...
Autores principales: | Bredesen, Dale E., Amos, Edwin C., Canick, Jonathan, Ackerley, Mary, Raji, Cyrus, Fiala, Milan, Ahdidan, Jamila |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4931830/ https://www.ncbi.nlm.nih.gov/pubmed/27294343 http://dx.doi.org/10.18632/aging.100981 |
Ejemplares similares
-
Reversal of cognitive decline: A novel therapeutic program
por: Bredesen, Dale E.
Publicado: (2014) -
Rationale for a Multi-Factorial Approach for the Reversal of Cognitive Decline in Alzheimer’s Disease and MCI: A Review
por: Rao, Rammohan V., et al.
Publicado: (2023) -
Inhalational Alzheimer's disease: an unrecognized—and treatable—epidemic
por: Bredesen, Dale E.
Publicado: (2016) -
Metabolic profiling distinguishes three subtypes of Alzheimer's disease
por: Bredesen, Dale E.
Publicado: (2015) -
ReCODE: A Personalized, Targeted, Multi-Factorial Therapeutic Program for Reversal of Cognitive Decline
por: Rao, Rammohan V, et al.
Publicado: (2021)